Gainers
- 89bio (NASDAQ:ETNB) shares increased by 86.0% to $15.03 during Thursday's pre-market session. The company's market cap stands at $1.1 billion.
- Aptevo Therapeutics (NASDAQ:APVO) stock increased by 65.95% to $2.34. The company's market cap stands at $4.6 million.
- Psyence Biomedical (NASDAQ:PBM) shares increased by 55.37% to $5.78.
- AquaBounty Techs (NASDAQ:AQB) shares increased by 44.73% to $1.65. The market value of their outstanding shares is at $4.4 million.
- MSP Recovery (NASDAQ:MSPR) shares moved upwards by 28.9% to $1.65. The market value of their outstanding shares is at $1.3 million.
- Adagio Medical Holdings (NASDAQ:ADGM) stock moved upwards by 26.38% to $2.06. The company's market cap stands at $25.0 million.
Losers
- Salarius Pharmaceuticals (NASDAQ:SLRX) shares declined by 21.9% to $4.34 during Thursday's pre-market session. The market value of their outstanding shares is at $2.8 million.
- BioCardia (NASDAQ:BCDA) shares declined by 11.41% to $1.36. The market value of their outstanding shares is at $8.9 million.
- CDT Equity (NASDAQ:CDT) stock declined by 11.0% to $0.8. The market value of their outstanding shares is at $2.7 million.
- Curanex Pharmaceuticals (NASDAQ:CURX) stock declined by 9.56% to $1.37. The company's market cap stands at $42.8 million.
- NLS Pharmaceutics (NASDAQ:NLSP) stock declined by 7.39% to $1.88. The company's market cap stands at $9.9 million.
- SciSparc (NASDAQ:SPRC) shares decreased by 7.16% to $4.15. The company's market cap stands at $2.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
APVOAptevo Therapeutics Inc
$1.51-5.63%
AQBAquaBounty Technologies Inc
$1.9317.0%
BCDABioCardia Inc
$1.40-0.71%
CDTCDT Equity Inc
$0.6820-2.96%
CURXCuranex Pharmaceuticals Inc
$0.805118.6%
ETNB89bio Inc
$14.70-%
MSPRMSP Recovery Inc
$1.38-%
NLSPNLS Pharmaceutics Ltd
$2.238.25%
PBMPsyence Biomedical Ltd
$3.07-%
SLRXSalarius Pharmaceuticals Inc
$3.80-3.80%
SPRCSciSparc Ltd
$4.36-28.4%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.